It is a jewelry & fashion accessories private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | ActiveMaclive Pharmaceuticals Private Limited, a active private limited company, was established on 22 January 2020 in Hyderabad, Telangana, India. Engaging in manufacturing within the jewelry & fashion accessories sector, it holds CIN: U33309TG2020PTC138594. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Jugal Kishore Mohar (Director), Ashish Mohar (Director), Sonal Mohar (Director). Past directors included Jugal Kishore Mohar. It holds ₹0.40 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat. No.506, Block Peony Ananda Homes 332/P Poetree Apartment, Narsingi, Gandi, Hyderabad, Telangana, 500089.
U33309TG2020PTC138594
138594
22 January 2020
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Maclive Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jugal Kishore Mohar | Director | 30 Mar 2020 | Current |
| Ashish Mohar | Director | 22 Jan 2020 | Current |
| Sonal Mohar | Director | 22 Jan 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maclive Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 82.23% increase. The company also saw a substantial fall in profitability, with a 33.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 900.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Maclive Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2023 | Hdfc Bank Limited | ₹0.40 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Maclive Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maclive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maclive Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Maclive Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Maclive Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.40 M with Charge ID 100766381 was registered on 24 Jul 2023. was completed.
The activity Jugal Kishore Mohar was appointed as a Director was appointed as a Director on 30 Mar 2020 & has been associated with this company since 5 years 8 months . was completed.
Progress on Ashish Mohar was appointed as a Director was appointed as a Director on 22 Jan 2020 & has been associated with this company since 5 years 11 months . was documented.
Sonal Mohar was appointed as a Director was appointed as a Director on 22 Jan 2020 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The CIN of Maclive Pharmaceuticals Private Limited is U33309TG2020PTC138594.
Maclive Pharmaceuticals Private Limited is headquartered at Flat. No.506, Block Peony Ananda Homes 332/P Poetree Apartment, Narsingi, Gandi, Hyderabad, Telangana, 500089.
Maclive Pharmaceuticals Private Limited was incorporated on 22 January 2020.
The current directors of Maclive Pharmaceuticals Private Limited are
The primary industry of Maclive Pharmaceuticals Private Limited is Jewelry & Fashion Accessories.
Maclive Pharmaceuticals Private Limited is unlisted.
The authorized capital of Maclive Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX